Johns Hopkins to scale back COVID dashboard and reportedly will update case, death and vaccine data daily and not every hour
admin Johns Hopkins University is planning to scale back its COVID data dashboard and will only…
Read Morevaccine
Pfizer and BioNTech say data show COVID vaccine has more than 70% efficacy in small children, with cases now rising in just 7 states
Pfizer and German partner BioNTech on Tuesday offered updated COVID vaccine data supporting efficacy in…
Read MoreJill Biden leaves isolation after twice testing negative, and Novavax vaccine is now allowed for U.S. teens
First lady Jill Biden left isolation on Sunday, after testing negative for COVID twice and…
Read MoreNovavax COVID-19 vaccine authorized for U.S. teens
The Food and Drug Administration authorized Novavax Inc.’s NVAX, -2.58% COVID-19 vaccine for use in…
Read MoreTrial finds 100-year-old tuberculosis vaccine offers protection against COVID to high-risk patients and may help with other infectious diseases
Data from a trial seeking to determine whether multiple injections of a tuberculosis vaccine developed…
Read MoreWorld’s only monkeypox vaccine maker uncertain it can meet demand, Bavarian Nordic CEO warns
“Demand keeps rising and it’s no longer certain that we can continue to meet the…
Read MoreChina closes Tibet’s Potala Palace over COVID outbreak, and Novavax stock is slammed by weak earnings and halving of sales guidance
Chinese authorities have closed Tibet’s Potala Palace after a small outbreak of COVID cases in…
Read MoreChina closes Tibet’s Potala Palace over COVID outbreak, and Novavax stock is slammed by weak earnings and halving of sales guidance
Chinese authorities have closed Tibet’s Potala Palace after a small outbreak of COVID cases in…
Read MoreOfficial U.S. tally of new cases may be declining, but at-home testing obscures data; Novavax opens trial of vaccine for very young children
The daily average of new U.S. cases may have started to decline based on official…
Read MoreOfficial U.S. tally of new cases may be declining, but at-home testing obscures data; Novavax opens trial of vaccine for very young children
The daily average of new U.S. cases may have started to decline based on official…
Read More